The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Open accessAbstract
BACKGROUND: Clostridium difficile infection is the leading cause of health care-associated diarrhea, and the bacterium can also be carried asymptomatically. The objective of this study was to identify host and bacterial factors associated with health care-associated acquisition of C. difficile infection and colonization. METHODS: We conducted a 15-month prospective study in six Canadian hospitals in Quebec and Ontario. Demographic information, known risk factors, potential confounding factors, and weekly stool samples or rectal swabs were collected. Pulsed-field gel electrophoresis (PFGE) was performed on C. difficile isolates to determine the genotype. Levels of serum antibodies against C. difficile toxins A and B were measured. RESULTS: A total of 4143 patients were included in the study; 117 (2.8%) and 123 (3.0%) had health care-associated C. difficile infection and colonization, respectively. Older age and use of antibiotics and proton-pump inhibitors were significantly associated with health care-associated C. difficile infection. Hospitalization in the previous 2 months; use of chemotherapy, proton-pump inhibitors, and H(2) blockers; and antibodies against toxin B were associated with health care-associated C. difficile colonization. Among patients with health care-associated C. difficile infection and those with colonization, 62.7% and 36.1%, respectively, had the North American PFGE type 1 (NAP1) strain. CONCLUSIONS: In this study, health care-associated C. difficile infection and colonization were differentially associated with defined host and pathogen variables. The NAP1 strain was predominant among patients with C. difficile infection, whereas asymptomatic patients were more likely to be colonized with other strains. (Funded by the Consortium de Recherche sur le Clostridium difficile.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Self-citationWarny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Self-citationNosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis
Kim, H. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1210 · Cited by 507
Clostridium difficile–Associated Diarrhea
Johnson, S., & Gerding, D. N. (1998) · Clinical Infectious Diseases · doi:10.1086/520276 · Cited by 441
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Self-citationDharmarajan, K., Hsieh, A. F., Lin, Z., Bueno, H., Ross, J. S., Horwitz, L. I., Barreto-Filho, J. A., Kim, N., Bernheim, S. M., Suter, L. G., et al. (2013) · JAMA · doi:10.1001/jama.2012.216476 · Cited by 1,060
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Clostridium difficile infection: review
Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E. J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03539-6 · Cited by 702
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
Eyre, D. W., Cule, M. L., Wilson, D. J., Griffiths, D., Vaughan, A., O'Connor, L., Ip, C. L. C., Golubchik, T., Batty, E. M., Finney, J. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216064 · Cited by 648
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 581
Carey-Ann, B. D., & Carroll, K. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-13 · Cited by 423
Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
Kriss, M., Hazleton, K. Z., Nusbacher, N. M., Martin, C. G., & Lozupone, C. A. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.07.003 · Cited by 416
Infections in Cancer Patients with Solid Tumors: A Review
Rolston, K. V. I. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0146-1 · Cited by 334
Dingle, K. E., Didelot, X., Quan, T. P., Eyre, D. W., Stoesser, N., Golubchik, T., Harding, R. M., Wilson, D. J., Griffiths, D., Vaughan, A., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30514-x · Cited by 328
Overutilization of proton-pump inhibitors: what the clinician needs to know
Heidelbaugh, J. J., Kim, A. H., Chang, R., & Walker, P. C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12437358 · Cited by 327
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission
Martin, J. S. H., Monaghan, T. M., & Wilcox, M. H. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.25 · Cited by 319
Understanding Clostridium difficile Colonization
Crobach, M. J. T., Vernon, J. J., Loo, V. G., Kong, L. Y., Péchiné, S., Wilcox, M. H., & Kuijper, E. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-17 · Cited by 318
Self-citationGastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Stojkovic Lalosevic, M., Milosavljevic, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 314
Clostridium difficile infection in the community: a zoonotic disease?
Hensgens, M. P. M., Keessen, E. C., Squire, M. M., Riley, T. V., Koene, M. G. J., de Boer, E., Lipman, L. J. A., & Kuijper, E. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03853.x · Cited by 290
Trifan, A., Stanciu, C., Girleanu, I., Stoica, O. C., Singeap, A. M., Maxim, R., Chiriac, S. A., Ciobica, A., & Boiculese, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i35.6500 · Cited by 286
Agrawal, M., Aroniadis, O. C., Brandt, L. J., Kelly, C., Freeman, S., Surawicz, C., Broussard, E., Stollman, N., Giovanelli, A., Smith, B., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000410 · Cited by 186
Chamberlain, R., & Lau, C. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s98280 · Cited by 177
Clostridium difficile – From Colonization to Infection
Schäffler, H., & Breitrück, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00646 · Cited by 174
Sartelli, M., Di Bella, S., McFarland, L. V., Khanna, S., Furuya-Kanamori, L., Abuzeid, N., Abu-Zidan, F. M., Ansaloni, L., Augustin, G., Bala, M., et al. (2019) · World Journal of Emergency Surgery · doi:10.1186/s13017-019-0228-3 · Cited by 159
Neemann, K., Eichele, D. D., Smith, P. W., Bociek, R., Akhtari, M., & Freifeld, A. (2012) · Transplant Infectious Disease · doi:10.1111/tid.12017 · Cited by 107
“The patient described herein had many of the wellidentified risk factors for CDI in the oncology population including recurrent hospitalizations, recent use of broad-spectrum antibiotics, chemotherapeutic agents, proton pump inhibitors, immunosuppression, and low albumin (1, 5, 13, 20, 23).”
BackgroundPanels and syndromic testing in clinical microbiology
Dien Bard, J., & McElvania, E. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.001 · Cited by 92
The role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
The Yin and Yang of Bacterial Resilience in the Human Gut Microbiota
Gibson, M. K., Pesesky, M. W., & Dantas, G. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.029 · Cited by 71
Kong, L. Y., Eyre, D. W., Corbeil, J., Raymond, F., Walker, A. S., Wilcox, M. H., Crook, D. W., Michaud, S., Toye, B., Frost, E., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy457 · Cited by 63
Self-citationClostridium difficile in the Long-Term Care Facility: Prevention and Management
Jump, R. L. P., & Donskey, C. J. (2015) · Current Geriatrics Reports · doi:10.1007/s13670-014-0108-3 · Cited by 35
The role of host molecules in communication with the resident and pathogenic microbiota: A review
White, J. R., Dauros-Singorenko, P., Hong, J., Vanholsbeeck, F., Phillips, A., & Swift, S. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100005 · Cited by 21
Kelly, K. N., & Monson, J. R. T. (2012) · Surgery (Oxford) · doi:10.1016/j.mpsur.2012.10.005 · Cited by 21
Using Technology to Enhance Antimicrobial Stewardship Impact in the Acute Care Setting
Cowman, K., Chen, V., Guo, Y., & Nori, P. (2020) · Current Treatment Options in Infectious Diseases · doi:10.1007/s40506-020-00218-5 · Cited by 10
Metadata
- Authors
- Loo, V. G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., Brassard, P., Dendukuri, N., Béliveau, C., Oughton, M., Brukner, I., & Dascal, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-11-03
- Volume
- 365
- Issue
- 18
- Pages
- 1693-1703
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2127424257
- Cited by
- 797
- References
- 29
- FWCI
- 44.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.